tiprankstipranks
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market

Ikena Oncology (IKNA) Ownership - Who Owns Ikena Oncology?

Compare
98 Followers

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,928,543Insider19.69%11,813,529
4,143,544Insider10.29%6,173,881
2,249,123Institution5.59%3,351,193
2,249,123Insider5.59%3,351,193
1,369,380Institution3.40%2,040,376
1,369,380Institution3.40%2,040,376
238,074Institution0.59%354,730
151,100Institution0.38%225,139
63,141Institution0.16%94,080
29,269Institution0.07%43,611

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,369,380Institution3.40%2,040,376
238,074Institution0.59%354,730
151,100Institution0.38%225,139
29,269Institution0.07%43,611
12,066Institution0.03%17,978
8,769Institution0.02%13,066
8,052Institution0.02%11,997
848Institution<0.01%1,264

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,051,228Institution2.61%1,724,014
318,152Institution0.79%521,769
62,711Institution0.16%93,439

FAQ

Who Owns Ikena Oncology (IKNA)?
Currently, no data Available
What percentage of Ikena Oncology (IKNA) stock is held by institutional investors?
Currently, no data Available
What percentage of Ikena Oncology (IKNA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Ikena Oncology (IKNA)?
David Bonita owns the most shares of Ikena Oncology (IKNA).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis